Metabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional study

Astrid Lavens,Christophe De Block,Philippe Oriot,Laurent Crenier,Jean-Christophe Philips,Michel Vandenbroucke,An-Sofie Vanherwegen,Frank Nobels,Chantal Mathieu,on behalf of the IQED Group of Experts

DOI: https://doi.org/10.1007/s00125-024-06273-7

IF: 8.2

2024-09-15

Diabetologia

Abstract:Metabolic abnormalities such as central obesity, insulin resistance, dyslipidaemia and hypertension, often referred to as 'the metabolic syndrome' (or 'combined metabolic abnormalities'), are increasingly being identified in people living with type 1 diabetes, accelerating the risk for CVD. As a result, in recent years, treatment in people living with type 1 diabetes has shifted to improving overall metabolic health rather than glucose control alone. In Belgium, diabetes care for people living with type 1 diabetes is centrally organised. The Initiative for Quality Improvement and Epidemiology in Diabetes, imposed by the Belgian health insurance system, has systematically collected data from patients on intensive insulin therapy treated in all 101 diabetes clinics in Belgium since 2001. The aim of this real-world study is to describe the evolution of treatment and metabolic health, including the prevalence of obesity and combined metabolic abnormalities, in people living with type 1 diabetes over the past 20 years, and to compare the treatment and prevalence of complications between those with and without combined metabolic abnormalities.

endocrinology & metabolism